Retention Disorders, Cognitive: Clinical Trials

3 trials for Retention Disorders, Cognitive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 2 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2
Phase 41Completed 1

Follow Retention Disorders, Cognitive: new trials by email Literature Review of Retention Disorders, Cognitive trials Research Report on Retention Disorders, Cognitive

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mini-Mental State (MMS-LS) and Sign Language
application of the mini-mental state test - Prelingual Deafness, Retention Disorders, Cognitive
Not applicableCompletedLille Catholic University1952011-06-172019-02-15
Legacy Intervention Family Enactment (LIFE)
LIFE Intervention - Pain, Retention Disorders, Cognitive
Not applicableCompletedUniversity of Alabama, Tuscaloosa1642009-06-012014-07-15
A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory Complaints
EGb 761® (Tanakan®), Placebo - Memory Disorders, Age-Related, Retention Disorders, Cognitive
Phase 4CompletedIpsen28782002-02-012019-01-15

Narrower conditions

Memory Disorders (3)  ·  Deafness (1)  ·  Pain (1)  ·  Sign Language (1)

Broader conditions

Nervous System Diseases (3)  ·  Neurobehavioral Manifestations (3)  ·  Neurologic Manifestations (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Behavior (1)  ·  Communication (1)  ·  Ear Diseases (1)  ·  Hearing Disorders (1)  ·  Hearing Loss (1)  ·  Language (1)  ·  Manual Communication (1)  ·  Nonverbal Communication (1)  ·  Otorhinolaryngologic Diseases (1)  ·  Sensation Disorders (1)

Interventions

Ginkgo biloba extract (1)

Sponsors

Ipsen (1)  ·  Lille Catholic University (1)  ·  University of Alabama, Tuscaloosa (1)

Countries

France (2)  ·  United States (1)

Top investigators

Charlotte Crinquette, MD (1)  ·  Corine Gilda Scemama-Ammar, MD (1)  ·  Isabelle Bouillevaux, MD (1)  ·  Isabelle Ridoux, MD (1)

Results publications

PMID 22959217, PMID 24667180, PMID 40640105

NIH funding

R21NR011112 (1)